Seaweeds are industrially exploited for obtaining pigments, polysaccharides, or phenolic compounds with application in diverse fields. Nevertheless, their rich composition in fiber, minerals, and proteins, has pointed them as a useful source of these components. Seaweed proteins are nutritionally valuable and include several specific enzymes, glycoproteins, cell wall-attached proteins, phycobiliproteins, lectins, or peptides. Extraction of seaweed proteins requires the application of disruptive methods due to the heterogeneous cell wall composition of each macroalgae group. Hence, non-protein molecules like phenolics or polysaccharides may also be co-extracted, affecting the extraction yield. Therefore, depending on the macroalgae and target protein characteristics, the sample pretreatment, extraction and purification techniques must be carefully chosen. Traditional methods like solid–liquid or enzyme-assisted extraction (SLE or EAE) have proven successful. However, alternative techniques as ultrasound- or microwave-assisted extraction (UAE or MAE) can be more efficient. To obtain protein hydrolysates, these proteins are subjected to hydrolyzation reactions, whether with proteases or physical or chemical treatments that disrupt the proteins native folding. These hydrolysates and derived peptides are accounted for bioactive properties, like antioxidant, anti-inflammatory, antimicrobial, or antihypertensive activities, which can be applied to different sectors. In this work, current methods and challenges for protein extraction and purification from seaweeds are addressed, focusing on their potential industrial applications in the food, cosmetic, and pharmaceutical industries.
It was my dream to fly high when I was young. . Ever since I attended the first international conference while I was a Ph.D. student, I realized that my dream was to organize such a meeting by myself. After several failed attempts and game-changing learning experiences while I was a post-doc (2013–2015), I successfully organized the first International Symposium on Phytochemicals in Medicine and Food (ISPMF) in Shanghai in 2015. After the first conference, the following ISPMF series just followed through; the second ISPMF was in Fuzhou, China in 2017 and the third ISPMF was in Kunming, China in 2018. The fourth ISPMF will be held in Xi'an, China in 2020. My success, I would rather say our success, if any, is not by chance but due to a team effort from a group of persistent and passionate scientists from all over the world. No task is too big when done together by all (attributed to Hawaiian Proverb). Choosing the right conference planning team is the most important lesson that I learned from my initial failed experiences. My dream of organizing an international conference came true when I met the president of The Phytochemical Society of Europe and after receiving support from several excellent universities in China. The guaranteed sponsorship that provides financial support, space, staff (mainly from students), etc. is essential for hosting a successful conference. I have had the privilege to obtain such kind of support from excellent universities in China. Experts from all over the world who participated in the foreign organizing committees as well as those from China set the bar high for selecting invited speakers. Although most journals rejected my request to publish a special issue from the first ISPMF, editors of Phytochemistry Reviews and Food Chemistry offered the first opportunity for the publication of a special issue. Now we have offers from several journals to publish presentations from plenary and invited lectures given during recent ISPMF conferences. Over time, more challenges have been overcome and more are yet to come. For example, how do we organize a successful international meeting that actively and proactively promotes collaborations and exchange of ideas during and after each conference, and how can we bring new talent from the next-generation scientists, and in particular students and junior scientists, into the field of phytochemicals in medicine and food? These are examples of continued challenges of our future conferences. Some approaches can be implanted such as setting up a social network among all participants, allowing effective and efficient communications, assigning voluntary and enthusiastic group leaders and co-leaders for different topics who can respond to the questions/comments, setting up student support channels to allow for basic and applied science questions and answers from experts in the field, or promoting exchange of students among participants from all over the world. My new dream has silently come true, that is, to start and to continue organizing a series of international conferences whereby humans from around the world can benefit in many ways from phytochemicals in medicine and food. Let food be thy medicine and medicine be the food (attributed to Hippocrates).
The double product (DP), systolic blood pressure multiplied by heart rate, is a surrogate measure of myocardial oxygen demand and cardiac workload used increasingly today in medicine. The double product is more strongly correlated with left ventricular mass than the daily blood pressure mean. The purpose of this study was to describe the normative circadian pattern of the double product in healthy normotensive young adults. We studied 125 men and 75 women, 23.0+/-3.3 (mean +/- SD) years of age, without medical history of hypertension and 24h ambulatory systolic/diastolic blood pressure mean consistently below 135/85 mm Hg. Subjects underwent ambulatory blood pressure monitoring at 30-minute intervals for 48 consecutive hours once each season of the year, yielding 930 protocol-correct blood pressure and heart rate time series. Subjects maintained their usual routine of diurnal activity and nocturnal sleep and avoided use of over-the-counter and other medication. Circadian rhythmicity in the double product was established by population multiple-component analysis. The double product rose rapidly from the lowest value, attained 3h before awaking from sleep at night, to a markedly elevated level at the commencement of morning activity. The double product was highest in the afternoon, roughly 7h after the commencement of diurnal activity. In both men and women, the shape of the high-amplitude circadian rhythm in the double product was best described by a complex model composed of three cosine curves having periods of 24h, 12h, and 6h. The 24h mean in the double product of 8092.51+/-42.76 (mean +/- SD) in men was significantly lower than that of 8353.17+/-37.48 in women (P < .001). The circadian double amplitude of the rhythm was statistically significantly greater (P < .001) in men (50% of the 24h mean) than women (44% of the 24h mean). The double product did not differ between seasons in women, but it did in men (P = .017) due to reduced heart rate in summer. The circadian pattern of large amplitude in the double product and its gender differences must be taken into account when using this variable to assess cardiac workload, risk of left ventricular hypertrophy, and efficiency of antihypertensive therapy.
Daytime office blood pressure measurements (OBPM), still recommended and utilized today for diagnosis and management of hypertension and categorization of cardiovascular disease (CVD) risk, fail to reveal clinically important features of the mostly predictable BP 24 h pattern and leads to a large proportion of individuals being misclassified. Most clinical guidelines now recommend ambulatory BP monitoring (ABPM) be applied to adult patients to confirm the OBPM-based diagnosis of hypertension, based on the high prevalence of masked hypertension and masked normotension plus demonstrated significantly better CVD prognostic value of around-the-clock ABPM than daytime OBPM. Nonetheless, there is yet no consensus of which parameter(s) and ABPM thresholds to utilize to diagnose hypertension. Findings of large prospective ABPM-based CVD outcome trials permit prospective evaluation of treatment and other induced changes in OBPM and ABPM during follow-up on CVD risk by incorporating multiple periodic (at least annual) patient ABPM assessments. They indicate: 1) asleep systolic BP (SBP) mean and sleep-time relative SBP decline (dipping) together are the most significant and only BP-derived prognostic markers of CVD risk; accordingly, around-the-clock ABPM should be the recommended method to diagnose true arterial hypertension and accurately assess CVD risk; and (2) treatment-induced lowering of the asleep SBP mean and rise of the sleep-time relative SBP decline towards the normal dipper BP pattern are both significantly protective against CVD events, thus constituting novel therapeutic targets to substantially better reduce CVD risk compared to the traditional approach that targets control of daytime OBPM or awake BP mean.
In this work, a practical experience that introduces the use of sonochemistry for nanomaterials synthesis is proposed with the aim of incorporating ultrasound concepts and their relationship with chemical reactions into chemistry undergraduate curricula. The proposed experience involves the synthesis of magnetic nanomaterials (bare and composite), followed by an evaluation of their characteristics, for example, average size and distribution, and relating them to theoretical aspects of ultrasound energy. Nanoparticle synthesis was carried out by the students following the procedures provided by the instructor. Students were required to interpret the results and create spaces for group discussion. Open discussion can be more productive for obtaining conclusions than answering closed questions. Students could observe that sonication provides shorter reaction times and increased reaction yield. In comparison to the conventional co-precipitation synthetic route, the ultrasound-assisted procedure reduces particle agglomeration and allows the formation of smaller particles. Changes in the size distribution, reaction time, and reaction yield were ascribed to physical effects (e.g., microjets and shockwaves) and chemical effects (e.g., generation of reactive free radicals) of ultrasound energy. The proposed practical experience could therefore contribute to consolidate theoretical aspects of ultrasound and experimental tasks that are specific to the area of sonochemistry synthesis, for a more comprehensive understanding of the different ultrasonic effects.
Abstract Cancer is a disease of the genome caused by somatic mutation and subsequent clonal selection. Several genes associated to cancer in humans, hereafter cancer genes, also show evidence of (germline) positive selection among species. Taking advantage of a large collection of mammalian genomes, we systematically looked for statistically significant signatures of positive selection using dN/dS models in a list of 430 cancer genes. Among these, we identified 63 genes under putative positive selection in mammals, which are significantly enriched in processes like crosslinking DNA repair. We also found evidence of a higher incidence of positive selection in cancer genes bearing germline mutations, like BRCA2, where positively selected residues are physically linked with known pathogenic variants, suggesting a potential association between germline positive selection and risk of hereditary cancer. Overall, our results suggest that genes associated with hereditary cancer have less selective constraints than genes related to sporadic cancer. Also, that the adaptive evolution of human cancer genes in mammals has been most likely driven by adaptive changes in important traits not directly related to cancer.